期刊
EXPERT REVIEW OF VACCINES
卷 13, 期 8, 页码 1027-1038出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14760584.2014.935767
关键词
dose schedule; dosing; HPV vaccination; immunogenicity; virus-like particle
类别
资金
- National Cancer Institute at the National Institutes of Health [R25T CA147832]
HPV vaccines can prevent multiple cancers in women and men. Difficulties in the cost and completion of the three-dose vaccine series have led to considerations of alternative dose schedules. In clinical trials, three doses given within a 12-month period versus the standard 6-month period yielded comparable results, and immunogenicity appears comparable with two doses in adolescent females compared to the three-dose series in adult females. While the data are generally supportive of moving to a two-dose vaccine schedule among young female adolescents, the adoption of a two-dose vaccine schedule still poses a potential risk to the strength and longevity of the immune response. Public health authorities implementing a two-dose vaccine schedule should devise risk management strategies to minimize the potential impact on cancer prevention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据